Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel favors novel arthritis drug from Pfizer
FDA panel favors novel arthritis drug from Pfizer
FDA panel favors novel arthritis drug from Pfizer
Submitted by
admin
on May 10, 2012 - 10:57am
Source:
Yahoo/AP
News Tags:
FDA
advisory panels
Pfizer
rheumatoid arthritis
tofacitinib
Headline:
FDA panel favors novel arthritis drug from Pfizer
Do Not Allow Advertisers to Use My Personal information
